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Abstract 
Background: PTSD in youth may lead to long-lasting psychological implications, 
educational difficulties and increased healthcare costs. Psychological interventions have 
been shown to be effective in its management. The objective of this study was to assess the 
cost-effectiveness of a range of psychological interventions for children and young people 
with PTSD.   
Methods: A decision-analytic model was constructed to compare costs and quality-adjusted 
life years (QALYs) of 10 psychological interventions and no treatment for children and young 
people with PTSD, from the perspective of the National Health Service and personal social 
services in England. Effectiveness data were derived from a systematic review and network 
meta-analysis. Other model input parameters were based on published sources, 
supplemented by expert opinion. 
Results: Cognitive therapy for PTSD, a form of individual trauma-focused cognitive 
behavioural therapy (TF-CBT), appeared to be the most cost-effective intervention for 
children and young people with PTSD (with a probability of 0.78 amongst the 11 evaluated 
options at a cost-effectiveness threshold of £20,000/QALY), followed by narrative exposure 
(another form of individual TF-CBT), play therapy, and other forms of individual TF-CBT. 
Narrative exposure had a 0.40 probability of being cost-effective amongst the remaining 10 
options after excluding cognitive therapy. EMDR, parent training and group TF-CBT 
occupied middle cost-effectiveness rankings. Family therapy and supportive counselling 
were less cost-effective than other active interventions. There was limited evidence for some 
interventions, in particular cognitive therapy for PTSD and parent training. 
Conclusions: Individual forms of TF-CBT and, to a lesser degree, play therapy appear to be 
cost-effective in the treatment of children and young people with PTSD. Family therapy and 
supportive counselling are unlikely to be cost-effective relative to other interventions. There 
is a need for well-conducted studies that examine the long-term clinical and cost-
effectiveness of a range of psychological treatments for children and young people with 
PTSD. 
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INTRODUCTION 
A considerable proportion of children and young people who are exposed to traumatic 
events, around 16%, will develop post-traumatic stress disorder (PTSD) (Alisic et al., 2014). 
Those who still have PTSD symptoms six months after the traumatic event are unlikely to 
recover without intervention (Hiller et al., 2016). If untreated, PTSD may lead to long-lasting 
psychological implications, educational difficulties and increased healthcare costs (Makley & 
Falcone, 2010). A number of psychological interventions have been shown to be effective in 
the treatment of PTSD in youth, predominantly trauma-focused cognitive behavioural 
therapy (TF-CBT) and, to a lesser extent, eye movement desensitisation and reprocessing 
(EMDR) (Mavranezouli et al., submitted). Published economic evaluations in this field have 
concluded that cognitive therapy for PTSD, an individual form of TF-CBT (Shearer et al., 
2018), individual TF-CBT (Mihalopoulos et al., 2015) and group TF-CBT (Aas, Iversen, Holt, 
Ormhaug, & Jensen, 2018) were more cost-effective than waitlist or treatment as usual; TF-
CBT was also found to be more cost-effective than counselling (Gospodarevskaya & Segal, 
2012) whereas group psychotherapy was likely more cost-effective than individual 
psychotherapy (McCrone et al., 2005). These economic studies evaluated a limited range of 
interventions available for the treatment of PTSD in youth and made very few comparisons 
between active interventions. Given the variety of available interventions and the need for 
efficient use of healthcare resources, the objective of this study was to examine the cost-
effectiveness of a range of psychological interventions for the treatment of PTSD in children 
and young people from the perspective of the National Health Service (NHS) and Personal 
Social Services (PSS) in England, using decision-analytic economic modelling. 
 
METHODS 
The analysis presented here informed the updating of national guidance for the management 
of PTSD in England, published by the National Institute for Health and Care Excellence 
(NICE) (National Institute for Health and Care Excellence, 2018). The guideline was 
developed by a guideline committee, an independent multi-disciplinary group of clinical 
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academics, health professionals and service user and carer representatives with expertise 
and experience in the field of PTSD. The committee contributed to the development of the 
economic model by providing advice on issues relating to the natural history and treatment 
patterns of PTSD in children and young people in the UK, as well as on model inputs in 
areas where evidence was lacking. 
 
Population 
The study population comprised children and young people (aged under 18 years) with 
clinically important post-traumatic stress symptoms, defined by a diagnosis of PTSD 
according to the Diagnostic and Statistical Manual of Mental Disorders (DSM), the World 
Health Organization (WHO) International Classification of Diseases (ICD) or similar criteria, 
or by clinically significant PTSD symptoms, indicated by a PTSD symptom score above 
threshold on a validated scale, that are present for more than 3 months after a traumatic 
event. 
 
Interventions 
The psychological interventions considered in the economic analysis were selected amongst 
interventions that were considered in a systematic review and NMA of randomised controlled 
trials (RCTs) of psychological, psychosocial and other non-pharmacological treatments for 
children and young people with PTSD (Mavranezouli et al., submitted; see online Appendix 2 
for inclusion criteria for the NMA). For the economic analysis we considered only 
interventions that had been tested on at least 40 individuals across RCTs included in the 
NMA of changes in PTSD symptoms at treatment endpoint, as this was deemed the 
minimum size of evidence base that could support a practice recommendation. Treatment as 
usual was not considered in the economic analysis as it comprised a heterogeneous group 
of non-specific interventions that were not clearly defined across studies. The NMA 
assessed different interventions within the TF-CBT class. TF-CBT is a broad class of 
psychological interventions that predominantly use trauma-focused cognitive, behavioural or 
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cognitive-behavioural techniques and exposure approaches to treatment. Although some 
interventions place their main emphasis on exposure (e.g. imaginal reliving, producing a 
written narrative or in vivo exposure) and others on cognitive techniques (e.g. restructuring 
of trauma-related appraisals), most use a combination. Interventions belonging to the TF-
CBT class were considered separately in the economic analysis to explore potential 
substantial differences in their relative cost-effectiveness. We decided to consider cognitive 
therapy for PTSD, one of the interventions within the TF-CBT class, in an exploratory 
economic analysis, although it had only been tested on 25 trial participants, because it was 
shown to be the most effective intervention in the NMA, and this finding, in combination with 
the robust evidence of effectiveness for all other interventions within the TF-CBT class, 
increased our confidence that cognitive therapy for PTSD was effective, despite of its limited 
evidence base. Nevertheless, we have also presented and interpreted results of the 
economic analysis after excluding cognitive therapy for PTSD from consideration. 
 
The economic analysis evaluated the following interventions: 
• Cognitive therapy for PTSD [TF-CBT] (included in exploratory analysis) 
• Cohen TF-CBT/cognitive processing therapy (CPT) [TF-CBT] 
• Narrative exposure therapy [TF-CBT] 
• Exposure/prolonged exposure therapy [TF-CBT] 
• Group CBT [TF-CBT] 
• EMDR 
• Family therapy 
• Play therapy 
• Parent training 
• Supportive counselling 
• No treatment, reflected in waitlist or no treatment RCT arms included in the NMA. 
 
Economic model structure 
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A hybrid decision-analytic model consisting of a decision-tree followed by a two-state Markov 
model was constructed using Microsoft Office Excel 2013 to estimate total costs and quality-
adjusted life years (QALYs) associated with each treatment. The model structure was 
determined by the natural history of PTSD in youth, its treatment patterns in the UK, and the 
availability of relevant clinical and epidemiological data (Figure 1).  
 
The model followed hypothetical cohorts of children and young people with PTSD, initiated 
on each of the treatment options assessed. The duration of treatment equalled 3 months (12 
weeks), according to the average treatment duration for children and young people with 
PTSD in trials and routine clinical practice (range 6-14 weeks). Following a course of 
treatment, children and young people in each cohort either remitted (entering a state of ‘no-
PTSD’) or failed to remit, remaining in a ‘PTSD’ state. In the next 3 months of follow-up, 
those who had remitted could remain in remission or relapse to PTSD. Conversely, those 
who had not remitted, could remain in the ‘PTSD’ state or remit (and move to ‘no-PTSD’). 
The length of the follow-up period immediately post-treatment was set at 3 months as this is 
the period for which most follow-up data are reported in RCTs of psychological interventions 
for PTSD. 
 
After that point, children and young people in each cohort entered the Markov model, run in 
3-month cycles, for consistency with the duration of the two periods of the decision-tree. In 
each cycle, children and young people could remain in the same health state or move 
between the states of ‘PTSD’ and ‘no-PTSD’. A half-cycle correction was applied.  
 
The time horizon of the analysis was 3 years (36 months), comprising 6 months in the 
decision tree and 2.5 years (10 x 3-month cycles) in the Markov component of the model. 
This time frame was deemed adequate to capture longer-term costs and effects of 
treatment, without making significant extrapolations and assumptions over the course of 
PTSD. 
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Death was not considered as there is no published evidence that mortality in children and 
young people with PTSD is higher than that of those in the general population.  
 
Effectiveness data 
We obtained effectiveness data from a systematic review and NMA of psychological and 
psychosocial interventions for children and young people with PTSD (Mavranezouli et al., 
submitted). We utilised the results of 2 NMAs of changes in PTSD symptoms: between 
baseline and treatment endpoint; and between baseline and 1-4 month follow-up. Details on 
the selection of the effectiveness data and the transformations required for use in the 
economic model are provided in online Appendix 1. 
 
The outputs of the NMA of changes in PTSD symptoms between baseline and treatment 
endpoint informed the intervention effects in the model period of 0-3 months. For the 3-6 
month follow-up period, the base-case economic analysis conservatively assumed that the 
active intervention effects were not retained and equalled the effect of no treatment; this was 
decided because the results of the NMA of changes in PTSD symptoms between baseline 
and 1-4-month follow-up showed considerable uncertainty. Data from this NMA were used in 
secondary analyses, to inform effects for each active intervention during 3-6 months after 
treatment initiation. 
 
Baseline probability of remission 
The probability of remission for no treatment (baseline) and for all model arms beyond 
treatment endpoint (i.e. for all treatment options during 3-6 months after treatment initiation 
in the base-case analysis and for all treatment options during 6-36 months after treatment 
initiation in both the base-case and secondary analyses) was estimated using naturalistic 
data on children and young people with PTSD in the community, who participated in a global 
mental health survey (Rosellini et al., 2018). We considered the community survey 
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participants to be representative of our study population, which was children and young 
people presenting in primary care with symptoms of PTSD. We preferred using community 
data on absolute effects for baseline (no treatment) to RCT data, as the latter reflect trial 
conditions and not necessarily care received in community (for a discussion on the selection 
of data for the baseline natural history model see Dias, Welton, Sutton, & Ades, 2013). 
Details on the methods used for the estimation of the baseline probability of remission are 
provided in online Appendix 2. 
 
Risk of relapse 
An annual risk of relapse of 0.10 was assumed across all treatment arms, based on the 
committee’s expert opinion and due to lack of relevant published evidence; this was 
translated into a 3-month probability of relapse of 0.026 assuming exponential function, 
which was applied in the 3-month follow-up period of the decision-tree and over the whole 
duration of the Markov model. This assumption was tested in sensitivity analysis. 
 
Utility data 
Utility scores express preferences for the health-related quality of life (HRQoL) in distinct 
health states and are necessary for the estimation of QALYs. Following a systematic 
literature search of utility data for PTSD, the base-case economic analysis used utility scores 
generated from HRQoL ratings of Australian adolescents and young adults aged 16-21 
years, some of whom had developed PTSD, who participated in a mental health survey 
(Gospodarevskaya, 2013). HRQoL was assessed with the Assessment of Quality of Life 
measure (http://www.aqol.com.au). The study sample was large (N=993) but its age was 
higher than the age of our study population. Moreover, the utility value of ‘no-PTSD’, derived 
from adolescents and young adults who had never experienced PTSD, is likely to be higher 
than the utility of ‘no-PTSD’ following remission, therefore use of utility data from this study 
has likely overestimated the utility value of the ‘no-PTSD’ state. 
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A secondary economic analysis was conducted that used utility data from children and 
young people aged 8-17 years with PTSD who participated in a RCT of cognitive therapy for 
PTSD 2-6 months after single trauma (Shearer et al., 2018). HRQoL was rated using the 
parent-completed Strengths and Difficulties Questionnaire, and subsequently mapped onto 
the Child Health Utility index 9D using a published algorithm (Furber, Segal, Leach, & Cocks, 
2014). Utility values were adjusted for baseline utility differences and potential clinical 
predictors (age, gender, group). Baseline HRQoL data from all trial participants determined 
the utility of the PTSD state. Data obtained from PTSD-free children at trial follow up, 
irrespective of group allocation, determined the utility of no-PTSD. The study sample, 
although very small (N=29), was directly relevant to the population of our analysis. The 
reported utility values suggested very narrow utility gains after remission from PTSD, 
resulting in the face validity of these data being questioned by the guideline committee; for 
this reason these data were only utilised in secondary analyses. 
 
Resource use and cost data 
The analysis included intervention costs (healthcare professional time), and costs relating to 
the ‘PTSD’ and ‘no-PTSD’ health states, including costs of primary, community and 
secondary healthcare and costs of personal social services. 
 
Intervention costs (Table 1) were calculated by combining resource use reported in RCTs 
included in the NMA that informed the economic analysis (i.e. number and duration of 
therapeutic sessions, number of therapists and participants for group interventions), modified 
to represent routine UK practice, with respective national unit costs. Descriptions of 
interventions in the RCTs that informed the NMAs and, subsequently, the economic analysis 
suggested that interventions were delivered by a range of therapists, including 
psychologists, social care professionals, counsellors, teachers, psychology graduate 
students or postdoctoral fellows, nurses, social workers, and lay counsellors. For the 
economic analysis, all interventions were assumed to be delivered by Band 7 therapists 
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(clinical psychologists) according to the NHS Agenda for Change for qualified Allied Health 
Professionals, to reflect routine practice in the UK. 
 
The therapists’ unit cost was estimated using a combination of data derived from national 
sources (British Association for Behavioural & Cognitive Psychotherapies, 2016; Curtis & 
Burns, 2017; National College for Teaching and Leadership, 2016) and included 
wages/salary, salary oncosts, capital and other overheads, qualification and supervision 
costs. The ratio of direct (face-to-face) to indirect (preparation and administrative tasks) 
therapists’ time was taken into account. Combining this information, the unit cost of a band 7 
clinical psychologist was estimated at £101 per hour of direct client contact. Details on the 
methods and sources used to estimate this figure are reported in online Appendix 3. 
 
Costs associated with the PTSD and no-PTSD health states were taken from the study by 
Shearer and colleagues (2018). NHS/PSS costs including staff time (general practitioner, 
nurse, paediatrician, clinical psychologist, etc.), hospital services, advice services, social 
services and medication were collected for all participants at baseline and over the trial 
period. Costs were adjusted for baseline cost differences and potential clinical predictors 
(age, gender, group). The reported 3-month baseline costs for all trial participants were 
attached to the PTSD state; reported 3-month costs for children who were PTSD-free at trial 
follow up, irrespective of allocation arm, were attached to the ‘no-PTSD’ state.  
 
Costs were expressed in 2017 prices, uplifted, where necessary, using the Hospital and 
Community Health Services Pay and Prices Index (Curtis & Burns, 2017). 
 
Discounting  
Costs and QALYs were discounted at 3.5% annually as recommended by NICE (National 
Institute for Health and Care Excellence, 2014). 
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Analysis 
To account for the uncertainty around input parameter point estimates, a probabilistic 
analysis was undertaken, in which input parameters were assigned probabilistic distributions 
(Briggs, Sculpher, & Claxton, 2006). Subsequently, 10,000 iterations were performed, each 
drawing random values out of the distributions fitted onto the model input parameters. Mean 
costs and QALYs for each treatment were calculated by averaging across the 10,000 
iterations. The Net Monetary Benefit (NMB) for each intervention was estimated for each 
iteration and averaged across the 10,000 iterations, determined by the formula   
NMB = E • そ – C 
where E and C are the effects (QALYs) and costs of each intervention, respectively, and そ 
represents the willingness-to-pay per unit of effectiveness, set at the NICE lower cost-
effectiveness threshold of £20,000/QALY (National Institute for Health and Care Excellence, 
2014). The intervention with the highest NMB is the most cost-effective option (Fenwick, 
Claxton, & Sculpher, 2001). 
 
The mean ranking by cost-effectiveness is reported for each intervention (out of 10,000 
iterations), where a rank of 1 suggests that an intervention is the most cost-effective 
amongst all evaluated treatment options. The probability of the intervention with the highest 
NMB being the most cost-effective option is also provided, calculated as the proportion of 
iterations in which the intervention has had the highest NMB amongst all interventions 
considered in the analysis. The probability of cost-effectiveness has been estimated in a 
step-wise approach, according to which the most cost-effective intervention is omitted at 
each step, and the probability of cost-effectiveness of the next most cost-effective 
intervention amongst the remaining treatment options is re-calculated. The probabilities 
estimated following this approach reflect the uncertainty around the cost-effectiveness not 
only of the most cost-effective intervention, but also the second, third, fourth, etc. most cost-
effective intervention in ranking, after more cost-effective interventions have been omitted 
from analysis. Finally, the cost-effectiveness acceptability frontier has been plotted, showing 
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the treatment with the highest mean NMB over different cost-effectiveness thresholds (そ), 
and the probability that this treatment is the most cost-effective among those assessed 
(Fenwick et al., 2001). We present two cost-effectiveness acceptability frontiers, one for the 
analysis that has considered all 11 treatment options, and another for the analysis that has 
included 10 treatment options, after excluding cognitive therapy for PTSD. 
 
Table 2 reports the values of all model input parameters. Deterministic values were used in 
deterministic one-way sensitivity analyses. The probability distributions show the types and 
range of distributions assigned to each parameter; estimation of distribution ranges was 
based on data reported in the published sources of evidence. 
 
Four probabilistic analyses were undertaken by combining the 2 alternative assumptions on 
the effectiveness of interventions at the 3-month follow-up with the 2 sets of utility data:  
 Scenario A (base-case analysis): use of utility data from Gospodarevskaya (2013); 
treatment effect between 3-6 months equalled that of no treatment 
 Scenario B: use of utility data from Gospodarevskaya (2013); treatment effect 
between 3-6 months estimated from the NMA of changes in PTSD symptoms 
between baseline and 1-4 month follow-up 
 Scenario C: use of utility data from Shearer and colleagues (2018); treatment effect 
between 3-6 months equalled that of no treatment 
 Scenario D: use of utility data from Shearer and colleagues (2018); treatment effect 
between 3-6 months was estimated from the NMA of changes in PTSD symptoms 
between baseline and 1-4 month follow-up 
 
One-way deterministic sensitivity analyses explored the impact of a change in the annual 
risk of relapse, which was varied between zero and 0.20. 
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Validation of the economic model 
The economic model was developed in collaboration with members of the guideline 
committee. All inputs and model formulae were systematically checked. The model was 
tested for logical consistency by setting input parameters to null and extreme values and 
examining whether results changed in the expected direction. All results were discussed with 
the committee to confirm their plausibility. 
 
RESULTS 
Table 3 shows the results of the base-case economic analysis [utility data from 
Gospodarevskaya (2013); no beneficial effect beyond treatment endpoint]. Interventions 
have been ordered from the most to the least cost-effective. The table provides, for each 
treatment, the mean number of QALYs, intervention costs and total costs per person, the 
mean NMB and ranking of each intervention, and its probability of being cost-effective in a 
step-wise approach, as explained earlier, at a threshold of £20,000/QALY. 
 
Cognitive therapy for PTSD was expected to be the most cost-effective intervention for 
children and young people with PTSD, with the highest NMB at the cost-effectiveness 
threshold of £20,000/QALY. This was followed by narrative exposure and play therapy. 
Exposure/prolonged exposure and Cohen TF-CBT/CPT completed the top 5 likely most 
cost-effective treatments. These were followed by EMDR, parent training, group TF-CBT, 
family therapy, supportive counselling and no treatment. It can be seen that, with the 
exception of cognitive therapy for PTSD, the next most cost-effective interventions up to 
(and including) parent training have probabilities of being cost-effective among remaining 
options that do not exceed 0.40, although increasingly fewer interventions are included in the 
analysis, indicating the uncertainty characterising the results for high-to-middle rankings. 
Notably, supportive counselling had a higher mean NMB but worse mean ranking than no 
treatment and, also, a 0.49 probability of being cost-effective when compared with no 
treatment alone, suggesting considerable uncertainty around its cost-effectiveness; these 
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findings are attributable to the skewed distributions of NMBs, combined with the fact that, 
according to the NMA that informed the economic analysis (Mavranezouli et al., submitted), 
the 95% credible intervals around the mean effect of supportive counselling versus no 
treatment crossed the line of no effect, indicating uncertainty in its clinical effectiveness. The 
cost-effectiveness plane (Figure 2) depicts the mean incremental costs and QALYs of all 
psychological interventions versus no treatment (placed at the origin). According to the cost-
effectiveness acceptability frontier, cognitive therapy appeared to be the most cost-effective 
option amongst the 11 treatment options assessed, at any cost-effectiveness threshold 
between zero and £40,000/QALY, with a 0.78 probability (amongst the 11 options assessed) 
at the threshold of £20,000/QALY (Figure 3). When cognitive therapy for PTSD was 
excluded from analysis, narrative exposure (another individual form of TF-CBT) appeared to 
be the most cost-effective intervention at any cost-effectiveness threshold between zero and 
£40,000/QALY, with a 0.40 probability at the threshold of £20,000/QALY amongst the 10 
remaining options (Figure 4). 
 
Under scenario B [utility data from Gospodarevskaya (2013); beneficial treatment effect up 
to 3-month follow-up], cognitive therapy for PTSD remained the most likely cost-effective 
intervention followed by Cohen TF-CBT/CPT, group TF-CBT, narrative exposure and parent 
training. As with base-case analysis, the probabilities of cost-effectiveness for interventions 
ranked between second and seventh places were low, ranging between 0.30 and 0.48 in 
spite of the fact that increasingly fewer interventions were included in the analysis, indicating 
uncertainty around the results for high-to-middle rankings. Group TF-CBT appeared to be 
the most cost-effective option for cost-effectiveness thresholds up to £2,000/QALY; cognitive 
therapy was expected to be the most cost-effective option at higher thresholds. The 
probability of cognitive therapy being the most cost-effective treatment at a threshold of 
£20,000/QALY was 0.67 amongst the 11 alternative options. When cognitive therapy was 
excluded from analysis, group TF-CBT was expected to be the most cost-effective option for 
thresholds up to £17,500/QALY, with Cohen TF-CBT/CPT becoming the most cost-effective 
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option at higher thresholds, and a probability of 0.30 at the £20,000/QALY threshold 
amongst the 10 remaining options. The improvements in the relative cost-effectiveness of 
Cohen TF-CBT/CPT, group TF-CBT and parent training are justified by the relatively large 
effects of these interventions in the NMA of changes in PTSD symptoms between baseline 
and 1-4-month follow-up, which informed scenario B. 
 
Under scenario C [utility data from Shearer and colleagues (2018); no beneficial effect 
beyond treatment endpoint], cognitive therapy remained the most likely cost-effective 
intervention followed by narrative exposure, play therapy, group TF-CBT and EMDR. Again 
the probabilities of cost-effectiveness for interventions ranked between second and seventh 
places were low, ranging between 0.21 and 0.43, confirming the uncertainty around the 
results for high-to-middle rankings. Supportive counselling appeared to be less cost-effective 
than no treatment. Cognitive therapy was expected to be the most cost-effective option at 
any cost-effectiveness threshold between zero and £40,000/QALY, with a 0.59 probability at 
the threshold of £20,000/QALY. When cognitive therapy was excluded from analysis, 
narrative exposure appeared to be the most cost-effective option at any cost-effectiveness 
threshold, with a 0.43 probability at the threshold of £20,000/QALY. This scenario utilised 
narrower utility gains after remission from PTSD, which favoured less costly interventions, 
such as group TF-CBT and EMDR, the relative cost-effectiveness of which improved.  
 
Under scenario D [utility data from Shearer and colleagues (2018); beneficial effect up to 3-
month follow-up], cognitive therapy was again expected to be the most cost-effective 
intervention, followed by group TF-CBT, Cohen TF-CBT/CPT, narrative exposure, and 
parent training. Probabilities of cost-effectiveness for interventions ranked from first to 
seventh places ranged from 0.31 to 0.50, suggesting considerable uncertainty around the 
results for high-to-middle rankings. Supportive counselling was likely less cost-effective than 
no treatment. Group TF-CBT appeared to be the most cost-effective treatment for cost-
effectiveness thresholds up to £15,500/QALY; cognitive therapy was expected to be the 
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most cost-effective option at higher thresholds, with a probability of only 0.31 at the 
£20,000/QALY threshold. When cognitive therapy was excluded from analysis, group TF-
CBT was the most cost-effective option at any threshold between zero and £40,000/QALY, 
with a 0.50 probability of being cost-effective at the £20,000/QALY threshold.  Changes in 
results under this scenario were affected by a combination of the relatively large effects of 
some interventions at 1-4-month follow-up, according to the NMA results (such as Cohen 
TF-CBT/CPT, group TF-CBT, and parent training), and the narrower utility gains after 
remission from PTSD, which favoured less costly interventions (such as group TF-CBT and 
EMDR). 
 
Full results of scenarios B, C and D are provided in online Appendix 4. 
 
In deterministic sensitivity analyses, results were overall robust to changes in the risk of 
relapse. Under scenarios A and B, there were only small changes in the ranking of 
interventions in middle places (top 4 interventions, including cognitive therapy, were 
unaffected). Under scenario C, there were more evident changes in ranking, in particular 
when the annual risk of relapse was increased to 0.20, however, the 2 likely most cost-
effective interventions, which included cognitive therapy, remained the same. Under 
scenario D, there were moderate changes in ranking in middle-to-lower places, especially 
when the annual risk of relapse was increased to 0.20, but the top 4 interventions, including 
cognitive therapy, remained unchanged. Results of deterministic sensitivity analyses are 
provided in online Appendix 5.  
 
DISCUSSION 
Overview of findings 
Individual forms of TF-CBT, in particular cognitive therapy and narrative exposure, and, to a 
lesser degree, play therapy appear to be cost-effective in the treatment of children and 
young people with PTSD more than 3 months after trauma. Evidence on the cost-
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effectiveness of individual TF-CBT was consistent across different interventions within the 
class, however, we did not find robust evidence of differential cost-effectiveness amongst 
different forms of individual TF-CBT. Family therapy and supportive counselling are not 
expected to be cost-effective relative to other interventions and, under some scenarios, 
supportive counselling appears to be less cost-effective than no treatment. In-between, there 
are interventions (EMDR, group TF-CBT and parent training) with modest relative cost-
effectiveness, which was affected by the alternative scenarios explored. Results were overall 
robust to assumptions tested through deterministic sensitivity analyses. 
 
Strengths and limitations 
Our analysis utilised effectiveness data derived from a systematic review and NMA of 
changes in PTSD symptoms (Mavranezouli et al., submitted). This methodology enabled us 
to consider information from both direct and indirect comparisons between interventions, and 
allowed simultaneous comparisons across all options while preserving randomisation 
(Caldwell, Ades, & Higgins, 2005). This approach for evidence synthesis is essential for 
populating model-based economic studies assessing more than two competing 
interventions. No inconsistency was detected between direct and indirect evidence. We used 
10,000 iterations of the NMA models in the economic analysis, which are representative of 
the full posterior distributions, and thus the uncertainty in the input estimates was 
incorporated in the economic model. 
 
The results of the NMAs of 1-4 month follow-up changes in PTSD symptoms showed 
considerable uncertainty due to the small number and size of the included studies. Thus, 
results based on these data (scenarios B and D) should be interpreted with caution. 
Nevertheless, the NMA that informed the base-case economic analysis (changes in PTSD 
symptoms between baseline and treatment endpoint) was based on more robust data. Both 
NMAs were characterised by moderate-to-high heterogeneity. The strengths and limitations 
of the NMAs that informed the economic analyses should be considered when interpreting 
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the cost-effectiveness results. Moreover, the quality and limitations of the RCTs considered 
in the NMAs have unavoidably impacted on the quality of the model input parameters. Some 
interventions were informed by limited evidence: effectiveness data on cognitive therapy and 
parent training were obtained from 25 and 49 individuals, respectively. Overall, the class of 
TF-CBT, in particular Cohen TF-CBT/CPT and group TF-CBT, had the largest evidence 
base. 
 
The economic model structure did not incorporate discontinuation due to the limited 
discontinuation data available. However, for the NMAs that informed the economic analysis, 
intention-to-treat continuous data were extracted, where available, so that discontinuation 
has been implicitly considered in the economic model outcomes. Moreover, the probabilistic 
analysis took into account the completion rates of the interventions in the RCTs that 
informed the economic analysis, so that the number of sessions reflected, up to a degree, 
the attrition rates characterising each intervention.  
 
The baseline risk of remission was estimated from a large longitudinal study that reported 
remission data for children and young people with PTSD (Rosellini et al., 2017), as the 
survey’s target population was deemed to be directly relevant to our study population. The 
risk of relapse was not available in published literature, and was therefore based on expert 
opinion. However, a range of values was tested in deterministic sensitivity analyses.  
 
The time horizon of the analysis was 3 years, which was considered adequate to capture 
longer-term effects and costs associated with a course of treatment for PTSD, without 
significant extrapolation over the natural course of PTSD.  
 
Utility data were derived from a systematic literature review. The review included only two 
studies, each with different strengths and limitations, as discussed earlier. The economic 
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analysis considered utility data from both studies in alternative scenarios, to explore the 
impact of use of different utility datasets on the results. 
 
Intervention costs were estimated from information provided in the studies included in the 
NMAs supplemented by the guideline committee’s expert opinion, in order to reflect routine 
UK practice. We assumed that all interventions were delivered by NHS Band 7 clinical 
psychologists in England, to reflect routine UK practice. The types of therapists delivering 
interventions in the RCTs that informed the economic analysis ranged from lay counsellors 
to clinical psychologists. Although the average level of expertise and seniority of therapists in 
the studies should be broadly equivalent with that assumed in our economic analysis, it is 
possible that in some RCTs therapists delivering the intervention had greater expertise than 
those expected to deliver the intervention in routine practice, meaning that the clinical and 
cost-effectiveness of interventions may have overall been overestimated in our analyses. 
This is a factor to consider when considering the transferability of RCT research to a practice 
setting. Nevertheless, we do not have indications of unequal spread of therapists’ expertise 
across different types of interventions across the RCTs that informed our analyses, and 
therefore we are confident that the risk of potential systematic bias around this issue is 
small. Regarding NHS/PSS costs incurred by children and young people with PTSD and 
those remitting from PTSD, these were taken from a small RCT due to lack of other 
evidence. 
 
Overall, our study is characterised by different strengths and limitations, which we have 
considered when constructing our model and interpreting the results of our analysis. We 
carried out probabilistic analyses, which took into account the uncertainty around model 
parameters and, where possible, we conducted secondary and deterministic sensitivity 
analyses to address uncertainties and gaps in the evidence. 
 
Comparison with existing economic evidence 
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Our findings are in agreement with previous economic evidence, which suggests that TF-
CBT, either individual or group, is more cost-effective than waitlist (Shearer et al., 2018),  
treatment as usual (Aas et al., 2018; Mihalopoulos et al., 2015) or counselling 
(Gospodarevskaya & Segal, 2012). Our economic analysis estimated the cost-effectiveness 
of a wider range of psychological interventions available for youth with PTSD, such as 
different forms of TF-CBT, EMDR, parent training, family therapy, play therapy and 
supportive counselling and allowed, for the first time, simultaneous comparisons of cost-
effectiveness across interventions, and their ranking from the most to the least cost-effective. 
 
Generalisability of the results and implications of the study 
Our analysis was conducted from the perspective of the NHS/PSS in England. Results may 
be generalisable to other settings with similar funding and structure of healthcare and 
personal social services and comparable care pathways for youth with PTSD. Conclusions 
on cost-effectiveness ultimately rely on the cost-effectiveness threshold adopted, and this 
depends on the policy makers’ willingness-to-pay for treatment benefits, which may vary 
across countries and health systems. 
 
Based on our findings, the NICE guideline on PTSD recommended individual TF-CBT for the 
treatment of children and young people with PTSD (National Institute for Health and Care 
Excellence, 2018). No recommendations were made for specific forms of individual TF-CBT, 
as we found no robust evidence that some individual forms of TF-CBT were more cost-
effective than others. Although play therapy was shown to be cost-effective, results were 
based on limited evidence (two RCTs). The committee had some difficulty in pinpointing the 
core active ingredient of play therapy and noted that the intervention resource use differed 
considerably between the two RCTs, suggesting a less well-defined intervention. Therefore 
no recommendation for play therapy was made. The committee considered the clinical and 
cost-effectiveness of EMDR and made a weaker (‘consider’) recommendation for children 
and young people aged 7-18 years who do not respond to or engage with TF-CBT. No 
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recommendation was made for group TF-CBT, as overall it was found to be less cost-
effective than individual TF-CBT, which was already recommended as a first-line option, so 
no further benefits were expected to be gained by a potential recommendation on group TF-
CBT. Also, no recommendation was made on parent training, because it had modest cost-
effectiveness relative to other interventions (it was less cost-effective than individual TF-CBT 
and, under the base-case analysis and some of the other scenarios, less cost-effective than 
EMDR), and this result was based on limited evidence (N=49). 
 
CONCLUSION 
Individual forms of TF-CBT and, to a lesser degree, play therapy appear to be cost-effective 
in the treatment of PTSD in youth. Family therapy and supportive counselling are probably 
not cost-effective relative to other interventions and, under some scenarios, supportive 
counselling appears to be less cost-effective than no treatment. In-between, there are 
interventions (EMDR, group TF-CBT and parent training) with modest relative cost-
effectiveness. Results should be interpreted with caution due to the limited evidence base 
characterising some of the interventions. There is a need for well-conducted studies that 
examine the relative clinical and cost-effectiveness of a range of psychological treatments 
for children and young people with PTSD, including assessment of longer-term costs and 
effects, to reduce the uncertainty and limitations characterising current evidence. 
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Key points 
 PTSD in youth may lead to long-lasting psychological implications, educational 
difficulties and increased healthcare costs. 
 A number of psychological interventions have been shown to be effective in the 
management of PTSD in youth. 
 The cost-effectiveness of interventions for PTSD in youth has implications for 
policy and practice. 
 Individual forms of TF-CBT and, to a lesser degree, play therapy appear to be 
cost-effective in the treatment of children and young people with PTSD. Family 
therapy and supportive counselling are likely less cost-effective relative to 
other interventions. 
 There is a need for well-conducted studies that examine the long-term clinical 
and cost-effectiveness of a range of psychological treatments for children and 
young people with PTSD. 
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Table 1: Intervention costs of psychological interventions for children and young 
people with PTSD (2017 prices) 
Intervention Resource use details 
Intervention 
cost per 
person 
Supportive counselling 12 x 75min individual sessions £1,520 
[TF-CBT] group CBT 
10 x 60min group sessions, 1 therapist and 6 
participants per group plus 1 x 60min individual 
orientation meeting 
£270 
[TF-CBT] Cohen TF-CBT/CPT 12 x 60min individual/family sessions £1,216 
[TF-CBT] cognitive therapy 10 x 90min individual sessions £1,520 
[TF-CBT] narrative exposure 6 x 60min individual sessions £608 
[TF-CBT] exposure/PE 14 x 60min individual sessions £1,419 
EMDR 8 x 45min individual sessions £608 
Family therapy 
4 x 75min group sessions, 1 therapist & 6 families 
per group, plus 2 hours of individual contact  
£287 
Play therapy 20 x 30min individual sessions £1,014 
Parent training 12 x45 min individual sessions £912 
No treatment No resource use £0 
All interventions assumed to be delivered by a Band 7 clinical psychologist 
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; PE: prolonged 
exposure; TF-CBT: trauma-focused cognitive behavioural therapy 
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Table 2. Economic model input parameters 
Input parameter Deterministic 
value 
Probability distribution 
(type, range) 
Sources – comments 
Odds ratios of remission versus no treatment at treatment endpoint 
 
Supportive counselling 
[TF-CBT] group CBT 
[TF-CBT] Cohen TF-CBT/CPT 
[TF-CBT] cognitive therapy 
[TF-CBT] narrative exposure 
[TF-CBT] exposure/PE 
EMDR 
Family therapy 
Play therapy 
Parent training 
 
 
2.97 
5.21 
8.43 
204.50 
15.14 
11.42 
6.09 
1.96 
11.52 
5.83 
95% CrI 
0.84 to 10.64 
1.87 to 14.60 
2.74 to 26.05 
34.36 to 1271.56 
3.99 to 59.20 
2.65 to 50.55 
1.52 to 24.80 
0.22 to 19.03 
1.51 to 90.65 
0.49 to 66.95 
 
Mavranezouli et al., 2019; standardised mean differences 
converted to odds ratios according to Chinn (2000); 
distribution based on 300,000 samples from posterior 
distributions outputted from NMAs, thinned by 30 to obtain 
10,000 values 
Odds ratios of remission versus no treatment at 3-month follow-up (secondary analysis only) 
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Supportive counselling 
[TF-CBT] group CBT 
[TF-CBT] Cohen TF-CBT/CPT 
[TF-CBT] cognitive therapy 
[TF-CBT] narrative exposure 
[TF-CBT] exposure/PE 
EMDR 
Parent training 
Family therapy 
Play therapy 
 
3.83 
15.51 
23.82 
No data 
5.54 
5.31 
2.94 
6.51 
No data 
No data 
95% CrI 
0.89 to 12.99 
2.90 to 91.56 
2.19 to 285.43 
No data 
1.09 to 28.05 
0.48 to 57.80 
0.18 to 47.13 
0.23 to 197.35 
No data 
No data  
 
Mavranezouli et al., 2019; Standardised Mean Differences 
converted to odds ratios according to Chinn (2000); 
distribution based on 300,000 samples from posterior 
distributions outputted from NMAs, thinned by 30 to obtain 
10,000 values. 3-6 month probability of remission for 
cognitive therapy borrowed from Cohen TF-CBT/CPT; 3-6 
month probability of remission for family therapy and play 
therapy assumed to equal that of no treatment 
 
Probability of remission – no treatment (also applied to all interventions between 3-6 months in base-case analysis & all interventions beyond 6 
months in all analyses) 
0-3 months from PTSD onset 
0-12 months from PTSD onset 
0-24 months from PTSD onset 
0-36 months from PTSD onset 
0.174 
0.370 
0.445 
0.500 
Beta: g=87.00; く=413.00 
Beta: g=185.19; く=314.81 
Beta: g=222.26; く=277.74 
Beta: g=250.00; く=250.00 
Rosellini et al., 2018; data averaged between children aged 
0-12 years and young people aged 13-24 years. See online 
Appendix 2 for details 
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Risk of relapse – all treatments 
3-month risk 
 
0.026 
 
Beta: g=2.60; く=97.40  
 
Expert opinion 
Utility values 
Base-case analysis 
PTSD – 3-month 
No-PTSD – 3-month 
Secondary analysis 
PTSD – 3-month 
No-PTSD – 3-month 
 
 
0.170 
0.218 
 
0.185 
0.193 
Beta distribution 
 
g=9.01; く=43.98 
g=1271.69; く=4575.15 
 
g=808; く=3,567 
g=2,618; く=10,940 
 
 
Gospodarevskaya, 2013; distribution estimated based on 
method of moments 
 
Shearer et al., 2018 
Intervention costs – resource use 
Number of sessions 
Supportive counselling 
[TF-CBT] group CBT 
[TF-CBT] Cohen TF-CBT/CPT 
[TF-CBT] cognitive therapy 
[TF-CBT] narrative exposure 
[TF-CBT] exposure/PE 
 
 
12 
10 
12 
10 
6 
14 
 
 
0.60: 10-12, 0.22: 6-9, 0.18: 3-5 
No distribution 
0.60: 10-12, 0.22: 6-9, 0.18: 3-5 
0.70: 8-10, 0.16: 6-7, 0.14: 3-5 
0.80: 5-6, 0.10: 4, 0.10: 3 
0.70: 11-14, 0.16: 7-10, 0.14: 3-6 
 
 
Different probabilities assigned to different numbers of 
sessions for individual therapies, based on intervention 
completion data and data on the actual and intended mean 
number of sessions reported in the RCTs that informed the 
economic analysis. The number of therapist sessions per 
person attending group therapies was not assigned a 
probability distribution because the number of group sessions 
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EMDR 
Family therapy 
Play therapy 
Parent training 
 
 
Unit cost of clinical psychologist Band 7 
8 
4 
20 
12 
 
 
£101 
0.60: 7-8, 0.22: 4-6, 0.18: 2-3 
No distribution 
0.60: 14-20, 0.22: 10-13, 0.18: 7-9 
0.60: 10-12, 0.22: 6-9, 0.18: 3-5 
 
Normal distribution 
SE = 0.05 of the mean 
remains the same, whether a participant attends the full 
course of treatment or not. 
 
 
 
Estimated using data from the British Association for 
Behavioural & Cognitive Psychotherapies (2016); Curtis & 
Burns (2017); National College for Teaching and Leadership 
(2016) (see online Appendix 3); distribution based on 
assumption 
3-month NHS/PSS health state cost 
PTSD 
No-PTSD 
 
£549 
£236 
Gamma distribution 
g=19.53; く=28.12 
g=10.37; く=22.74 
Shearer and colleagues (2018) data, expressed in 2017 
prices using the Hospital and Community Health Services 
Pay and Prices Index (Curtis & Burns, 2017)  
Annual discount rate 0.035 No distribution Applied to costs and outcomes (National Institute for Health 
and Care Excellence, 2014)  
CBT: cognitive behavioural therapy; CPT: cognitive processing therapy; CrI: credible intervals; EMDR: eye movement desensitisation and reprocessing; NHS: 
national health service; PE: prolonged exposure; PSS: personal social services; PTSD: post-traumatic stress disorder; SE: standard error; TF: trauma-focused 
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Table 3. Base-case results of economic modelling (Scenario A) [utility data from 
Gospodarevskaya (2013); no beneficial effect beyond treatment endpoint] 
Intervention 
Mean per person 
NMB (£/ 
person) 
Mean 
rank 
Prob* 
QALY 
Intervention 
cost (£) 
Total 
cost (£) 
(at a threshold of 
£20,000/QALY) 
[TF-CBT] cognitive therapy 2.467  1,202   4,347   44,993   1.57  0.78 
[TF-CBT] narrative exposure  2.322  517   4,484   41,966   3.35  0.40 
Play therapy 2.297  719   4,827   41,109   4.68  0.34 
[TF-CBT] exposure/PE  2.297  1,089   5,200   40,742   5.35  0.27 
[TF-CBT] Cohen TF-CBT/CPT 2.268  915   5,188   40,178   5.91  0.21 
EMDR 2.241  460   4,897   39,920   5.88  0.30 
Parent training 2.244  684   5,099   39,788   6.50  0.39 
[TF-CBT] group CBT 2.224  270   4,798   39,687   5.83  0.72 
Family therapy 2.168  287   5,133   38,222   8.20  0.43 
Supportive counselling 2.183  1,141   5,902   37,753   9.57  0.49 
No treatment 2.121  0    5,113   37,304   9.16  1.00 
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net 
monetary benefit; PE: prolonged exposure; Prob: probability of cost-effectiveness; TF-CBT: trauma-
focused cognitive behavioural therapy 
*estimated in a step-wise approach, according to which the most cost-effective intervention is omitted 
at each step, and the probability of cost-effectiveness of the next most cost-effective intervention 
amongst the remaining treatment options is re-calculated 
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Figure 1. Schematic diagram of the economic model 
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Figure 2. Cost-effectiveness plane: base-case analysis [utility data from 
Gospodarevskaya (2013); no beneficial effect beyond treatment endpoint] 
Results for 1,000 children and young people with PTSD. 
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Figure 3. Cost-effectiveness acceptability frontier: base-case analysis [utility data 
from Gospodarevskaya (2013); no beneficial effect beyond treatment endpoint] – 
cognitive therapy for PTSD included in analysis 
 
Comparison across 11 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], cognitive therapy for PTSD [TF-CBT], narrative exposure therapy 
[TF-CBT], exposure/PE [TF-CBT], eye movement desensitisation and reprocessing (EMDR), family 
therapy, play therapy, parent training, no treatment 
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Figure 4. Cost-effectiveness acceptability frontier: base-case analysis [utility data 
from Gospodarevskaya (2013); no beneficial effect beyond treatment endpoint] – 
cognitive therapy for PTSD excluded from analysis
 
Comparison across 10 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], narrative exposure therapy [TF-CBT], exposure/PE [TF-CBT], eye 
movement desensitisation and reprocessing (EMDR), family therapy, play therapy, parent training, no 
treatment 
  
38 
 
Cost-effectiveness of psychological interventions for children and young people with 
post-traumatic stress disorder 
 
Ifigeneia Mavranezouli, Odette Megnin-Viggars, David Trickey, Richard Meiser-Stedman, 
Caitlin Daly, Sofia Dias, Sarah Stockton, Stephen Pilling. 
 
Online supplementary material 
Appendix 1: Selection of effectiveness data and transformation for use in the economic analysis 
Appendix 2: Estimation of the baseline probability of remission 
Appendix 3: Estimation of the unit cost of a clinical psychologist working for the National Health 
Service (NHS) in England [salary Band 7 according to the NHS Agenda for Change for qualified Allied 
Health Professionals] 
 
Appendix 4: Results of secondary probabilistic economic analyses 
Appendix 5: Results of deterministic sensitivity analyses 
Appendix 6: References in the online supplementary material 
 
 
 
  
39 
 
Appendix 1: Selection of effectiveness data and transformation for use in the 
economic analysis 
 
Effectiveness data were obtained from a systematic literature review and network meta-
analyses (NMAs) of randomised clinical trials (RCTs) of psychological and psychosocial 
interventions for children and young people with clinically important PTSD symptoms 
(Mavranezouli et al., submitted). The NMAs were conducted within a Bayesian framework 
using Markov Chain Monte Carlo simulation techniques implemented in WinBUGS 1.4.3 
(Lunn, Thomas, Best, & Spiegelhalter, 2000; Spiegelhalter, Thomas, Best, & Lunn, 2003). 
 
The NMAs included 2 analyses of changes in PTSD symptom scores (between baseline and 
treatment endpoint; and between baseline and 1-4 month follow-up) and one analysis of 
dichotomous remission data at treatment endpoint. Although dichotomous data are more 
suitable for use in economic modelling as they can be easily translated into probabilities of 
events that correspond directly to the model health states, available dichotomous remission 
data were sparse and did not cover all interventions of interest in the economic analysis (9 
RCTs assessing 7 treatment options reported dichotomous remission at treatment endpoint; 
in contrast, continuous PTSD symptom change score data between baseline and treatment 
endpoint were available for 17 treatment options in 29 RCTs). Therefore, the economic 
analysis utilised the results of the NMAs of changes in PTSD symptom scores, which were 
reported as standardised mean differences (SMDs), and were subsequently transformed into 
log-odds ratios (LORs) of effect (Chinn, 2000), so that they could be utilised in the economic 
analysis, as described in our companion paper (Mavranezouli et al., submitted; online 
Appendix 3). 
 
The log-odds ratios of remission of each intervention versus no treatment (which served as 
the baseline treatment) were exponentiated into odds ratios. Subsequently, the probability of 
remission for each intervention, which was utilised in the economic model, was estimated 
using the following formulae: 
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件券建結堅懸結券建件剣券 喧堅剣決 噺   墜鳥鳥鎚岫怠袋墜鳥鳥鎚岻  (1) 
and 
剣穴穴嫌 噺   長銚鎚勅鎮沈津勅 椎追墜長岫怠貸長銚鎚勅鎮沈津勅 椎追墜長岻  頚迎 (2) 
where baseline prob is the probability of remission for the baseline treatment (no treatment), 
OR is the odds ratio of remission for each intervention versus no treatment as estimated 
following exponentiation of the log-odds ratios obtained from the NMA, and odds is the odds 
of each intervention to achieve remission.  
 
The NMA models were run in WinBUGS with an initial burn-in period of 100,000 iterations, 
followed by 300,000 further iterations, thinned by 30 so as to obtain 10,000 iterations for use 
in the economic model. These 10,000 samples are representative of the full posterior 
distributions, and thus the uncertainty in the input estimates is incorporated in the economic 
model. 
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Appendix 2: Estimation of the baseline probability of remission 
 
The probability of remission for no treatment (baseline) was obtained from a study reporting 
long-term data on the course of PTSD derived from 1575 people with lifetime PTSD who had 
participated in 22 World Health Organization (WHO) World Mental Health surveys (Rosellini 
et al., 2018). The study reported rates of remission of PTSD over 120 months (10 years) 
following PTSD onset for different age groups, including data on children aged 0-12 years 
and young people aged 13-24 years, in the form of a graph. Digital software 
(http://www.digitizeit.de) was used to read and extract the cumulative proportions of children 
aged 0-12 years and young people aged 13-24 years that remitted from PTSD at 3 months, 
6 months, 12 months, 24 months, and 36 months from PTSD onset. The values at each time 
point were averaged between the two age groups, to cover the whole range of the economic 
analysis study population. The extracted values were used to estimate the probability of 
remission between 0-3 months, 3-12 months, 12-24 months and 24-36 months in the model, 
conditional on not having achieved remission prior to the beginning of each interval. The 
estimated probabilities of remission during these time periods were subsequently 
transformed into 3-month probabilities that were used to inform the economic model. 
 
The table below shows the estimated cumulative probability of remission for children and 
young people at 3, 12, 24 and 36 months from PTSD onset; the probability of remission 
between 0-3, 3-12, 12-24 and 24-36 months (conditional on not having achieved remission 
prior to the beginning of the interval); and the 3-monthly probability of remission during these 
time periods. 
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Probability of remission over time in children and young people with PTSD, as 
estimated based on data extracted from Rosellini and colleagues (2018) 
Time from 
PTSD onset 
Cumulative 
probability of 
remission 
Time interval 
Probability of 
remission over the 
time interval* 
3-monthly 
probability during 
the time interval* 
3 months 0.174 0-3 months 0.174 0.174 
12 months 0.370 3-12 months 0.238 0.087 
24 months 0.445 12-24 months 0.118 0.031 
36 months 0.500 24-36 months 0.100 0.026 
* conditional on not having achieved remission prior to the beginning of the interval 
 
The economic analysis evaluated interventions for the treatment of children and young 
people with PTSD initiated more than three months after a traumatic event. The economic 
model was thus assumed to start at month 3 from PTSD onset. Therefore, remission data 
corresponding to 0-3 months after PTSD onset were not used in the economic analysis. 
 
The estimated 3-month probability of remission over 3-12 months from PTSD onset informed 
months 0-9 of the economic model: these data were applied onto the no treatment arm. 
They also informed all model arms in months 3-6 of the economic model in the base-case 
analysis, and all model arms in months 6-9 in all analyses of the economic model, as the 
course of PTSD after 6 months of treatment was assumed to be independent of the 
treatment received. 
 
The 3-month probability of remission over 12-24 months from PTSD onset informed all 
model arms in months 9-21 of the economic model. The 3-month probability of remission 
over 24-36 months from PTSD onset informed all model arms in months 21-36 of the 
economic model; this 3-month probability was also utilised over the period of 36-39 months 
from PTSD onset (i.e. months 33-36 of the economic model) for simplicity. 
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Appendix 3: Estimation of the unit cost of a clinical psychologist working for 
the National Health Service (NHS) in England [salary Band 7 according to the 
NHS Agenda for Change for qualified Allied Health Professionals] 
 
Cost element Unit cost (2017 price) Source 
Wages – salary (annual) £38,951 
Curtis & Burns, 2017; unit cost of 
community-based scientific & 
professional staff, including allied health 
professionals (Agenda for Change band 
7) 
Salary on-costs (annual) £9,864 
Overheads – staff (annual) £11,960 
Overheads - non-staff 
(annual) 
£18,647 
Capital overheads (annual) £5,125 
Qualifications (total) £12,386 
Based on a mean clinical psychologist 
training cost estimate of £159,420 
(National College for Teaching and 
Leadership, 2016), annuitised using the 
formula reported in Netten, Knight, 
Dennett, Cooley, & Slight (1998), 
assuming a useful working life of 25 
years, a time from obtaining the 
qualification until retirement of 44 years, 
and an equal distribution of the useful 
working life over the period of 44 years 
due to lack of specific information on this 
distribution. 
Supervision (annual) £316 
Based on the unit cost of an Agenda for 
Change band 8a clinical psychologist 
(Curtis & Burns, 2017) providing 1.5 
hour of supervision per month, delivered 
in groups of 4 participants (British 
Association for Behavioural & Cognitive 
Psychotherapies, 2016 and expert 
advice); qualification costs included, as 
described above. 
SUM of cost elements 
(annual) 
£97,249 
 
Working time 
42.6 weeks /year 
37.5 hours /week 
(1,599 hours) 
Curtis & Burns, 2017 
Total cost per hour £61  
Ratio of direct to indirect 
time* 
60:40 
assumption based on expert opinion and 
a review of respective ratios reported in 
the literature for clinical psychologists 
and other therapists delivering 
psychological interventions (Curtis & 
Burns, 2017) 
Estimated cost per hour of 
direct contact 
£101  
* ratio of face-to-face time to time for preparation and other administrative tasks 
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Appendix 4: Results of secondary probabilistic economic analyses 
 
Results of Scenario B [utility data from Gospodarevskaya (2013); beneficial effect up 
to 3-month follow-up] 
 
 
Intervention 
Mean per person 
NMB (£/ 
person) 
Mean 
rank 
Prob* 
QALY 
Intervention 
cost (£) 
Total 
cost (£) 
(at a threshold of 
£20,000/QALY) 
[TF-CBT] cognitive therapy 2.482  1,204   4,271   45,373   1.88  0.67 
[TF-CBT] Cohen TF-CBT / CPT 2.390  911   4,453   43,348   3.90  0.30 
[TF-CBT] group CBT 2.362  270   3,971   43,269   3.35  0.48 
[TF-CBT] narrative exposure 2.335  517   4,414   42,296   4.71  0.31 
Parent training 2.320  685   4,645   41,751   5.47  0.36 
[TF-CBT] exposure / PE 2.326  1,089   5,033   41,495   6.26  0.33 
Play therapy 2.297  719   4,840   41,094   6.31  0.46 
EMDR 2.268  461   4,731   40,636   6.65  0.62 
Supportive counselling 2.244  1,135   5,534   39,341   8.61  0.59 
Family therapy 2.169  287   5,135   38,245   9.12  0.56 
No treatment 2.121  0    5,114   37,312   9.76  1.00 
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net 
monetary benefit; PE: prolonged exposure; Prob: probability of cost-effectiveness; TF-CBT: trauma-
focused cognitive behavioural therapy 
*estimated in a step-wise approach, according to which the most cost-effective intervention is omitted 
at each step, and the probability of cost-effectiveness of the next most cost-effective intervention 
amongst the remaining treatment options is re-calculated 
 
 
Scenario B - Cost-effectiveness plane 
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Scenario B - Cost-effectiveness acceptability frontier - cognitive therapy for PTSD included 
in analysis 
 
 
Comparison across 11 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], cognitive therapy for PTSD [TF-CBT], narrative exposure therapy 
[TF-CBT], exposure/PE [TF-CBT], eye movement desensitisation and reprocessing (EMDR), family 
therapy, play therapy, parent training, no treatment 
 
 
 
Scenario B - Cost-effectiveness acceptability frontier - cognitive therapy for PTSD excluded 
from analysis 
 
 
Comparison across 10 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], narrative exposure therapy [TF-CBT], exposure/PE [TF-CBT], eye 
movement desensitisation and reprocessing (EMDR), family therapy, play therapy, parent training, no 
treatment 
46 
 
Results of Scenario C [utility data from Shearer and colleagues (2018); no beneficial 
effect beyond treatment endpoint] 
 
 
Intervention 
Mean per person 
NMB (£/ 
person) 
Mean 
rank 
Prob* 
QALY 
Intervention 
cost (£) 
Total 
cost (£) 
(at a threshold of 
£20,000/QALY) 
[TF-CBT] cognitive therapy 2.224  1,203   4,373   40,108   2.05  0.59 
[TF-CBT] narrative exposure 2.200  517   4,502   39,501   3.11  0.43 
Play therapy 2.196  715   4,843   39,075   4.85  0.31 
[TF-CBT] group CBT 2.184  270   4,807   38,872   5.05  0.21 
EMDR 2.187  459   4,908   38,824   5.59  0.28 
[TF-CBT] exposure / PE  2.196  1,089   5,221   38,700   6.47  0.25 
Parent training 2.187  682   5,112   38,635   6.61  0.36 
[TF-CBT] Cohen TF-CBT / CPT 2.191  911   5,202   38,622   6.66  0.52 
Family therapy 2.175  287   5,139   38,357   7.59  0.41 
No treatment 2.167  0    5,118   38,224   7.82  0.84 
Supportive counselling 2.177  1,137   5,911   37,631   10.21  1.00 
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net 
monetary benefit; PE: prolonged exposure; Prob: probability of cost-effectiveness; TF-CBT: trauma-
focused cognitive behavioural therapy 
*estimated in a step-wise approach, according to which the most cost-effective intervention is omitted 
at each step, and the probability of cost-effectiveness of the next most cost-effective intervention 
amongst the remaining treatment options is re-calculated 
 
 
 
Scenario C - Cost-effectiveness plane 
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Scenario C - Cost-effectiveness acceptability frontier - cognitive therapy for PTSD included 
in analysis 
 
 
Comparison across 11 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], cognitive therapy for PTSD [TF-CBT], narrative exposure therapy 
[TF-CBT], exposure/PE [TF-CBT], eye movement desensitisation and reprocessing (EMDR), family 
therapy, play therapy, parent training, no treatment 
 
 
 
Scenario C - Cost-effectiveness acceptability frontier - cognitive therapy for PTSD excluded 
from analysis 
 
Comparison across 10 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], narrative exposure therapy [TF-CBT], exposure/PE [TF-CBT], eye 
movement desensitisation and reprocessing (EMDR), family therapy, play therapy, parent training, no 
treatment  
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Results of Scenario D [utility data derived from Shearer and colleagues (2018); 
beneficial effect up to 3-month follow-up] 
 
 
Intervention 
Mean per person 
NMB (£/ 
person) 
Mean 
rank 
Prob* 
QALY 
Intervention 
cost (£) 
Total 
cost (£) 
(at a threshold of 
£20,000/QALY) 
[TF-CBT] cognitive therapy 2.227  1,203   4,271   40,276   2.79  0.31 
[TF-CBT] group CBT 2.208  270   3,966   40,190   2.54  0.50 
[TF-CBT] Cohen TF-CBT / CPT 2.212  910   4,452   39,798   4.26  0.34 
[TF-CBT] narrative exposure 2.204  518   4,412   39,661   4.40  0.34 
Parent training 2.201  681   4,642   39,376   5.45  0.37 
EMDR 2.193  462   4,727   39,130   6.25  0.31 
Play therapy 2.197  718   4,833   39,113   6.40  0.44 
[TF-CBT] exposure / PE 2.202  1,087   5,035   39,004   7.02  0.57 
Family therapy 2.176  287   5,132   38,395   8.68  0.32 
No treatment 2.169  0    5,113   38,261   8.88  0.55 
Supportive counselling 2.189  1,136   5,529   38,244   9.32  1.00 
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net 
monetary benefit; PE: prolonged exposure; Prob: probability of cost-effectiveness; TF-CBT: trauma-
focused cognitive behavioural therapy 
*estimated in a step-wise approach, according to which the most cost-effective intervention is omitted 
at each step, and the probability of cost-effectiveness of the next most cost-effective intervention 
amongst the remaining treatment options is re-calculated 
 
 
 
Scenario D - Cost-effectiveness plane 
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Scenario D - Cost-effectiveness acceptability frontier - cognitive therapy for PTSD included 
in analysis 
 
 
Comparison across 11 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], cognitive therapy for PTSD [TF-CBT], narrative exposure therapy 
[TF-CBT], exposure/PE [TF-CBT], eye movement desensitisation and reprocessing (EMDR), family 
therapy, play therapy, parent training, no treatment 
 
 
 
Scenario D - Cost-effectiveness acceptability frontier - cognitive therapy for PTSD excluded 
from analysis 
 
Comparison across 10 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], narrative exposure therapy [TF-CBT], exposure/PE [TF-CBT], eye 
movement desensitisation and reprocessing (EMDR), family therapy, play therapy, parent training, no 
treatment 
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Appendix 5: Results of deterministic sensitivity analyses 
 
Scenario A [utility data from Gospodarevskaya (2013); no beneficial effect beyond treatment endpoint] 
 
 
Annual probability of relapse 0.10 Annual probability of relapse 0.00 Annual probability of relapse 0.20 
Intervention 
NMB 
(£/person) 
Intervention 
NMB 
(£/person) 
Intervention 
NMB 
(£/person) 
[TF-CBT] cognitive therapy 43,790 [TF-CBT] cognitive therapy  45,324  [TF-CBT] cognitive therapy  42,375  
[TF-CBT] narrative exposure  41,256 [TF-CBT] narrative exposure   42,310  [TF-CBT] narrative exposure   40,279  
Play therapy 40,209 Play therapy  41,175  Play therapy  39,314  
[TF-CBT] exposure / PE  39,782 [TF-CBT] exposure / PE   40,744  [TF-CBT] exposure / PE   38,889  
[TF-CBT] Cohen TF-CBT / CPT 39,265 [TF-CBT] Cohen TF-CBT / CPT  40,127  [TF-CBT] group CBT  38,466  
[TF-CBT] group CBT 39,129 EMDR  39,885  [TF-CBT] Cohen TF-CBT / CPT  38,464  
EMDR  39,127 [TF-CBT] group CBT  39,841  EMDR  38,421  
Parent training 38,728 Parent training  39,473  Parent training  38,034  
Family therapy 37,457 Family therapy  37,939  Family therapy  37,004  
No treatment 37,075 No treatment  37,464  No treatment  36,708  
Supportive counselling 36,823 Supportive counselling  37,388  Supportive counselling  36,294  
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net monetary benefit; PE: prolonged exposure; TF-
CBT: trauma-focused cognitive behavioural therapy 
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Scenario B [utility data from Gospodarevskaya (2013); beneficial effect up to 3-month follow-up] 
 
 
Annual probability of relapse 0.10 Annual probability of relapse 0.00 Annual probability of relapse 0.20 
Intervention 
NMB 
(£/person) 
Intervention 
NMB 
(£/person) 
Intervention 
NMB 
(£/person) 
[TF-CBT] cognitive therapy  44,079  [TF-CBT] cognitive therapy  45,637  [TF-CBT] cognitive therapy  42,639  
[TF-CBT] group CBT  42,684  [TF-CBT] group CBT  43,747  [TF-CBT] group CBT  41,687  
[TF-CBT] Cohen TF-CBT / CPT  42,534  [TF-CBT] Cohen TF-CBT / CPT  43,680  [TF-CBT] Cohen TF-CBT / CPT  41,459  
[TF-CBT] narrative exposure  40,919  [TF-CBT] narrative exposure  41,931  [TF-CBT] narrative exposure  39,981  
Parent training  40,258  Play therapy  41,175  Parent training  39,471  
Play therapy  40,209  Parent training  41,095  Play therapy  39,314  
[TF-CBT] exposure / PE  39,454  [TF-CBT] exposure / PE  40,301  [TF-CBT] exposure / PE  38,723  
EMDR  38,722  EMDR  39,329  EMDR  38,150  
Supportive counselling  38,247  Supportive counselling  38,929  Supportive counselling  37,605  
Family therapy  37,457  Family therapy  37,939  Family therapy  37,004  
No treatment  37,075  No treatment  37,464  No treatment  36,708  
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net monetary benefit; PE: prolonged exposure; TF-
CBT: trauma-focused cognitive behavioural therapy 
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Scenario C [utility data from Shearer and colleagues (2018); no beneficial effect beyond treatment endpoint] 
 
 
Annual probability of relapse 0.10 Annual probability of relapse 0.00 Annual probability of relapse 0.20 
Intervention 
NMB 
(£/person) 
Intervention 
NMB 
(£/person) 
Intervention 
NMB 
(£/person) 
[TF-CBT] cognitive therapy  39,791  [TF-CBT] cognitive therapy  40,385  [TF-CBT] cognitive therapy  39,243  
[TF-CBT] narrative exposure  39,405  [TF-CBT] narrative exposure  39,813  [TF-CBT] narrative exposure  39,027  
[TF-CBT] group CBT   38,814  Play therapy  39,132  [TF-CBT] group CBT   38,558  
Play therapy   38,758  [TF-CBT] group CBT  39,090  Play therapy   38,411  
EMDR  38,603  EMDR  38,897  EMDR  38,330  
[TF-CBT] exposure / PE  38,344  [TF-CBT] exposure / PE  38,717  No treatment  38,067  
[TF-CBT] Cohen TF-CBT / CPT   38,276  [TF-CBT] Cohen TF-CBT / CPT   38,610  [TF-CBT] exposure / PE  37,999  
Parent training  38,263  Parent training  38,552  Family therapy  37,999  
No treatment   38,209  Family therapy  38,361  Parent training  37,994  
Family therapy  38,174  No treatment  38,360  [TF-CBT] Cohen TF-CBT / CPT  37,966  
Supportive counselling  37,166  Supportive counselling  37,385  Supportive counselling  36,962  
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net monetary benefit; PE: prolonged exposure; TF-
CBT: trauma-focused cognitive behavioural therapy 
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Scenario D [utility data from Shearer and colleagues (2018); beneficial effect up to 3-month follow-up] 
 
 
Annual probability of relapse 0.10 Annual probability of relapse 0.00 Annual probability of relapse 0.20 
Intervention 
NMB 
(£/person) 
Intervention 
NMB 
(£/person) 
Intervention 
NMB 
(£/person) 
[TF-CBT] group CBT   40,191  [TF-CBT] group CBT   40,602  [TF-CBT] group CBT   39,805  
[TF-CBT] cognitive therapy  39,903  [TF-CBT] cognitive therapy  40,506  [TF-CBT] cognitive therapy  39,345  
[TF-CBT] Cohen TF-CBT / CPT  39,542  [TF-CBT] Cohen TF-CBT / CPT  39,985  [TF-CBT] Cohen TF-CBT / CPT  39,126  
[TF-CBT] narrative exposure  39,275  [TF-CBT] narrative exposure  39,667  [TF-CBT] narrative exposure  38,911  
Parent training  38,855  Parent training  39,180  Parent training  38,551  
Play therapy   38,758  Play therapy   39,132  Play therapy   38,411  
EMDR  38,446  EMDR  38,681  EMDR  38,225  
[TF-CBT] exposure / PE  38,218  [TF-CBT] exposure / PE  38,545  No treatment  38,067  
No treatment   38,209  Family therapy  38,361  Family therapy  37,999  
Family therapy  38,174  No treatment  38,360  [TF-CBT] exposure / PE  37,934  
Supportive counselling  37,718  Supportive counselling  37,982  Supportive counselling  37,469  
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net monetary benefit; PE: prolonged exposure; TF-
CBT: trauma-focused cognitive behavioural therapy 
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